126,080.00
+46,980.00
+(59.39%)
At close: December 17 at 1:45:27 PM GMT-3
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 13 | 10 | 17 | 18 |
Avg. Estimate | 15.03B | 16.3B | 60.46B | 63.9B |
Low Estimate | 14.36B | 15.77B | 59.89B | 56.92B |
High Estimate | 15.69B | 16.96B | 61.23B | 66.92B |
Year Ago Sales | 12.9B | 15.14B | 54.14B | 60.46B |
Sales Growth (year/est) | 16.56% | 7.72% | 11.68% | 5.68% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
MSCL.SN | -- | -- | -- | -- |
S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
Maintains | JP Morgan: Neutral to Neutral | 1/13/2025 |
Maintains | B of A Securities: Buy to Buy | 1/7/2025 |
Maintains | Barclays: Overweight to Overweight | 1/6/2025 |
Maintains | JP Morgan: Neutral to Neutral | 12/6/2024 |
Maintains | Keefe, Bruyette & Woods: Market Perform to Market Perform | 12/3/2024 |
Downgrade | HSBC: Buy to Hold | 11/26/2024 |